Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Virginia
M.D. Anderson Cancer Center
Mayo Clinic
City of Hope Medical Center
Blueprint Medicines Corporation
Astex Pharmaceuticals, Inc.
Newave Pharmaceutical Inc
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
University of Southern California
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
University of Wisconsin, Madison
Mayo Clinic
University of Washington
Wake Forest University Health Sciences
St. Jude Children's Research Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ohio State University Comprehensive Cancer Center
Massachusetts General Hospital
Yale University
City of Hope Medical Center
National Cancer Institute (NCI)
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Rutgers, The State University of New Jersey